Differential expression of complement proteins in cerebrospinal fluid from active multiple sclerosis patients

Area of Science:

• Neuroimmunology
• Proteomics
• Central Nervous System Disorders

Background:

• Multiple sclerosis (MS) is a complex central nervous system demyelinating disease.
• The immunopathogenesis of MS involves intricate immune system interactions.
• Understanding molecular changes in MS is crucial for developing effective treatments.

Purpose of the Study:

• To identify differential proteins in cerebrospinal fluid (CSF) of active MS patients compared to controls.
• To investigate the role of the complement system in active MS pathogenesis.
• To explore potential protein biomarkers for MS.

Main Methods:

• Utilized 2-D Difference Gel Electrophoresis (2-D DIGE) for CSF protein separation.
• Performed quantitative proteomic analysis on CSF samples.
• Confirmed protein expression levels using Western blotting.

Main Results:

• Identified seven differentially expressed proteins in CSF from active MS patients.
• Found three of these proteins are related to the complement system.
• Confirmed elevated levels of Complement C4b (gamma chain) in active MS patients (P < 0.01).

Conclusions:

• Complement activation is implicated in the pathogenesis of active MS.
• Elevated Complement C4b in CSF serves as a potential biomarker for MS.
• These proteomic findings provide quantitative evidence for complement involvement in MS disease progression.